South State Corp maintained its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,900 shares of the medical instruments supplier’s stock at the end of the 2nd quarter. South State Corp’s holdings in DENTSPLY SIRONA were worth $447,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Veritas Asset Management LLP lifted its position in shares of DENTSPLY SIRONA by 2.6% during the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock worth $402,083,000 after acquiring an additional 157,616 shares in the last quarter. Gateway Investment Advisers LLC lifted its position in shares of DENTSPLY SIRONA by 8.4% during the second quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock worth $1,258,000 after acquiring an additional 1,499 shares in the last quarter. Bronfman E.L. Rothschild L.P. lifted its position in shares of DENTSPLY SIRONA by 78.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock worth $771,000 after acquiring an additional 5,236 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of DENTSPLY SIRONA by 4.3% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 673,830 shares of the medical instruments supplier’s stock worth $42,074,000 after acquiring an additional 27,860 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its position in shares of DENTSPLY SIRONA by 3.1% during the first quarter. Schwab Charles Investment Management Inc. now owns 710,579 shares of the medical instruments supplier’s stock worth $44,369,000 after acquiring an additional 21,456 shares in the last quarter. Hedge funds and other institutional investors own 93.97% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/south-state-corp-has-447000-position-in-dentsply-sirona-inc-xray/1559387.html.

Shares of DENTSPLY SIRONA Inc. (XRAY) traded up 0.47% during midday trading on Wednesday, hitting $59.72. The company had a trading volume of 277,363 shares. The firm’s market capitalization is $13.71 billion. The stock has a 50 day moving average price of $57.67 and a 200 day moving average price of $61.87. DENTSPLY SIRONA Inc. has a 1-year low of $52.54 and a 1-year high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.76 EPS. On average, equities analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.59%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -10.09%.

XRAY has been the topic of several recent research reports. Goldman Sachs Group, Inc. (The) downgraded DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and dropped their target price for the stock from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. BidaskClub downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, June 10th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a research report on Tuesday, July 11th. They set a “buy” rating and a $74.00 target price on the stock. Finally, Credit Suisse Group restated an “outperform” rating and set a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $65.73.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.